Multiple Sclerosis Treatments on the Horizon: BTK Inhibitors

home / leaders-in-neurology / multiple-sclerosis-treatments-on-the-horizon-btk-inhibitors

Experts in neurology discuss ongoing studies surrounding the use of BTK inhibitors and the role they are likely to play in the future treatment of multiple sclerosis.

© 2024 MJH Life Sciences

All rights reserved.